top
Search terms
Results 1 - 10 of 11 - ordered by :
Pages: 1 2
Ehjournal

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors In the Cleveland Cohort, comprised ...

European Heart Journal, Li, Xinmin S., Obeid, Slayman, Klingenberg, Roland, Gencer, Baris, Mach, François, Räber, Lorenz, Windecker, Stephan, Rodondi, Nicolas, Nanchen, David, Muller, Olivier, ...

Date : 08/03/2017 Item size : 394514 bytes
Ehjournal

Conclusion An early benefit of early generation DES in primary PCI for STEMI with a reduction in TVR and a trend towards less definite ST is offset in subsequent years by an increased risk of very ...

European Heart Journal, Kalesan, Bindu, Pilgrim, Thomas, Heinimann, Katja, Räber, Lorenz, Stefanini, Giulio G., Valgimigli, Marco, da Costa, Bruno R., Mach, François, Lüscher, Thomas F., ...

Date : 01/04/2012
Ehjournal

Based on personal and familial history of premature cardiovascular disease and LDL-cholesterol levels, two validated algorithms for diagnosis of clinical FH were used: the Dutch Lipid Clinic Network ...

European Heart Journal, Nanchen, David, Gencer, Baris, Auer, Reto, Räber, Lorenz, Stefanini, Giulio G., Klingenberg, Roland, Schmied, Christian M., Cornuz, Jacques, Muller, Olivier, Vogt, Pierre, ...

Date : 21/09/2015 Item size : 306214 bytes
Ehjournal

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors In the Cleveland Cohort, comprised ...

European Heart Journal, Li, Xinmin S., Obeid, Slayman, Klingenberg, Roland, Gencer, Baris, Mach, François, Räber, Lorenz, Windecker, Stephan, Rodondi, Nicolas, Nanchen, David, Muller, Olivier, ...

Date : 09/03/2017
Ehjcardiovascrec

Conclusion Our data provide pharmacological and genetic evidence that endogenous PARP1 is required for atherogenesis in vivo by increasing adhesion molecules with endothelial activation, enhancing ...

Cardiovascular Research, von Lukowicz, Tobias, Hassa, Paul O., Lohmann, Christine, Borén, Jan, Braunersreuther, Vincent, Mach, François, Odermatt, Bernhard, Gersbach, Monika, Camici, Giovanni ...

Date : 01/04/2008 Item size : 301684 bytes
Ehjournal

Citation Xinmin S. Li, Slayman Obeid, Roland Klingenberg, Baris Gencer, François Mach, Lorenz Räber, Stephan Windecker, Nicolas Rodondi, David Nanchen, Olivier Muller, Melroy X. Miranda, ...

European Heart Journal, Li, Xinmin S., Obeid, Slayman, Klingenberg, Roland, Gencer, Baris, Mach, François, Räber, Lorenz, Windecker, Stephan, Rodondi, Nicolas, Nanchen, David, Muller, Olivier, ...

Date : 14/03/2017 Item size : 185972 bytes
Ehjournal

Conclusion An early benefit of early generation DES in primary PCI for STEMI with a reduction in TVR and a trend towards less definite ST is offset in subsequent years by an increased risk of very ...

European Heart Journal, Kalesan, Bindu, Pilgrim, Thomas, Heinimann, Katja, Räber, Lorenz, Stefanini, Giulio G., Valgimigli, Marco, da Costa, Bruno R., Mach, François, Lüscher, Thomas F., ...

Date : 01/04/2012 Item size : 525162 bytes
Ehjournal

Citation Xinmin S. Li, Slayman Obeid, Roland Klingenberg, Baris Gencer, François Mach, Lorenz Räber, Stephan Windecker, Nicolas Rodondi, David Nanchen, Olivier Muller, Melroy X. Miranda, ...

European Heart Journal, Li, Xinmin S., Obeid, Slayman, Klingenberg, Roland, Gencer, Baris, Mach, François, Räber, Lorenz, Windecker, Stephan, Rodondi, Nicolas, Nanchen, David, Muller, Olivier, ...

Date : 14/03/2017
Ehjournal

Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors In the Cleveland Cohort, comprised ...

European Heart Journal, Li, Xinmin S., Obeid, Slayman, Klingenberg, Roland, Gencer, Baris, Mach, François, Räber, Lorenz, Windecker, Stephan, Rodondi, Nicolas, Nanchen, David, Muller, Olivier, ...

Date : 14/03/2017 Item size : 428564 bytes
Ehjournal

Introduction Proprotein convertase subtilisin kexin 9 (PCSK9) has received considerable attention in the last decade as a promising target for lipid-lowering therapy.1,2 Proprotein convertase ...

European Heart Journal, Gencer, Baris, Montecucco, Fabrizio, Nanchen, David, Carbone, Federico, Klingenberg, Roland, Vuilleumier, Nicolas, Aghlmandi, Soheila, Heg, Dik, Räber, Lorenz, Auer, Reto, ...

Date : 07/02/2016 Item size : 359297 bytes